Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical esketamine gargle for prevention of postoperative sore throat after double-lumen endobronchial intubation
ChiCTR2100044061Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Post-extubation sore throat (POST) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Incidence of postoperative sore throat. Started Mar 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2100044061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044061.